Eramol Wins Contract for Clinical Drug Trial

The Newcastle Upon Tyne Hospitals NHS Foundation Trust has successfully awarded a contract for the provision of a Double Blind Pragmatic Randomised Controlled Trial (BOAT) to Eramol (UK) Ltd. This contract spans 24 months, with an option to extend for an additional year. The trial aims to assess the efficacy of Azithromycin in reducing exacerbations in patients suffering from Bronchiectasis.

Eramol (UK) Ltd, located in Sevenoaks, Kent, has been tasked with implementing this significant clinical trial. The project is essential for understanding how long-term antibiotics can be best utilized for patients with Bronchiectasis, as there is ongoing uncertainty about the most effective treatment protocols.

This initiative reflects the Trust's commitment to advance healthcare through rigorous clinical research. The funding allocated for this trial totals approximately £312,354.95. As the project progresses, the Trust hopes to gather valuable insights that can lead to enhanced treatment options for patients grappling with this condition.

For more information, you can visit the official websites of the Newcastle Upon Tyne Hospitals NHS Foundation Trust and Eramol (UK) Ltd to stay updated on the trial's developments.